CPRI
Capri Holdings Limited
CPRI has the edge over RIVN overall, supported by stronger valuation and lower modeled downside.
RIVN
Rivian Automotive, Inc.
RIVN's outlook is improving, though it still trails on the overall score.
CPRI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
CPRI's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CPRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $14.12 | -31% |
| Forward | 9.4x | $20.38 | — |
| Current | 12x | $20.38 | — |
| Fair | 13x | $23.01 | +13% |
| Expensive | 21x | $36.91 | +81% |
Historical ranges are pointers, not guarantees.
CPRI's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 9.4x next year's earnings, in its cheap range.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
CPRI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CPRI's earnings to grow and its profitability to improve, with its revenue holding steady.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over CPRI on the outlook, with more favorable revenue expectations.
CPRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.17 | +23% |
| Q3 2026 | $1.77 | +$11.64 |
| Q2 2026 | $1.30 | +$10.75 |
| Q1 2026 | $1.14 | +$11.14 |
| Q4 2025 | -$4.30 | +$4.24 |
| Q3 2025 | -$9.87 | -$6.82 |
| Q2 2025 | -$9.45 | -$6.97 |
| Q1 2025 | -$10.00 | -$8.04 |
| Q4 2024 | -$8.54 | -547% |
CPRI has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
CPRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $809M | -5.5% |
| Q2 2026 | $769M | -3.5% |
| Q1 2026 | $796M | -23% |
| Q4 2025 | $1B | -19% |
| Q3 2025 | $856M | -21% |
| Q2 2025 | $797M | -25% |
| Q1 2025 | $1B | -15% |
| Q4 2024 | $1.3B | -12% |
CPRI's revenue has slid since its 2021 peak: $809M last quarter, down 5.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.2% | +2.6 points |
| Q2 2026 | 2.2% | +0.2 points |
| Q1 2026 | -3.4% | +7.8 points |
| Q4 2025 | 4.5% | +51 points |
| Q3 2025 | -1.4% | +2.1 points |
| Q2 2025 | 2% | +2.8 points |
| Q1 2025 | -11% | +33 points |
| Q4 2024 | -47% | -55 points |
CPRI has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over CPRI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
CPRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $36M | +$101M |
| Q2 2026 | $48M | +$69M |
| Q1 2026 | -$83M | +$105M |
| Q4 2025 | $183M | -34% |
| Q3 2025 | -$65M | -383% |
| Q2 2025 | -$21M | -153% |
| Q1 2025 | -$188M | -$182M |
| Q4 2024 | $278M | -11% |
CPRI has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
CPRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.9% | -5.7M shares |
| 1 year | -7.9% | -9.4M shares |
| 3 years | -6.1% | -7.2M shares |
| 5 years | -28% | -43.9M shares |
| Available history | -27% | -41.8M shares |
CPRI has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $150M |
| Q2 2026 | $54M |
| Q1 2026 | $79M |
| Q4 2025 | — |
| Q3 2025 | $1M |
| Q2 2025 | $1M |
| Q1 2025 | — |
| Q4 2024 | — |
CPRI spent $283M buying back its own shares over the past year, more than ten times what it spent the year before.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CPRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q4 2023 | 3.9x | Elevated |
| Q3 2023 | 3.6x | Elevated |
| Q2 2023 | 2.5x | Moderate |
| Q1 2023 | 1.9x | Healthy |
CPRI's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.9 years a year ago.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CPRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.5 | Neutral |
| Stochastic | 88.5 | Overbought |
CPRI's weekly RSI is 64 (neutral) and its Stochastic is 88 (overbought).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
CPRI PE vs Consumer Cyclical Sector
| Metric | CPRI | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 36% below |
| PE % | 43 | 47 | 4 pts below |
CPRI is trading at 12x earnings, a 36% discount to the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
CPRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.0 | 20% above |
| 20 week MA | $16.0 | 27% above |
| 50 week MA | $19.1 | 6.9% above |
| 100 week MA | $19.5 | 4.5% above |
| 200 week MA | $30.6 | 33% below |
CPRI has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
CPRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.5 | $42.4 | +13% |
| 2021 | $42.4 | $61.7 | +45% |
| 2022 | $61.7 | $55.7 | -9.7% |
| 2023 | $55.7 | $50.2 | -9.8% |
| 2024 | $50.2 | $21.0 | -58% |
| 2025 | $21.0 | $25.0 | +19% |
| 2026 YTD | $25.0 | $20.4 | -18% |
CPRI has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.